{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:26:48Z","timestamp":1794432408847,"version":"4.9.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T00:00:00Z","timestamp":1713225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T00:00:00Z","timestamp":1713225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Palliat Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Breathlessness is a prevalent symptom affecting the quality of life (QOL) of Amyotrophic Lateral Sclerosis (ALS) patients. This systematic review explored the interventions for controlling breathlessness in ALS patients, emphasizing palliative care (PALC), non-invasive ventilation (NIV), opioids, and non-pharmacological strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A comprehensive search of PubMed, Cochrane Library, and Web of Science databases was conducted. Eligibility criteria encompassed adults with ALS or motor neuron disease experiencing breathlessness. Outcomes included QOL and symptom control. Study designs comprised qualitative studies, cohort studies, and randomized controlled trials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Eight studies were included, most exhibiting low bias risk, comprising one randomized controlled trial, three cohort studies, two comparative retrospective studies, and two qualitative studies (interviews). Most studies originated from Europe, with one from the United States of America. The participants totaled 3423, with ALS patients constituting 95.6%. PALC consultations significantly improved symptom assessment, advance care planning, and discussions about goals of care. NIV demonstrated efficacy in managing breathlessness, with considerations for device limitations. Opioids were effective, though predominantly studied in non-ALS patients. Non-pharmacological strategies varied in efficacy among patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The findings underscore the need for individualized approaches in managing breathlessness in ALS. PALC, NIV, opioids, and non-pharmacological strategies each play a role, with unique considerations. Further research, especially ALS-specific self-management studies, is warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12904-024-01429-z","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T00:16:12Z","timestamp":1713226572000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Optimizing breathlessness management in amyotrophic lateral sclerosis: insights from a comprehensive systematic review"],"prefix":"10.1186","volume":"23","author":[{"given":"Catarina Bico","family":"Filipe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuno Reis","family":"Carreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4665-585X","authenticated-orcid":false,"given":"Paulo","family":"Reis-Pina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,16]]},"reference":[{"issue":"2","key":"1429_CR1","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.chest.2018.06.035","volume":"155","author":"S Niedermeyer","year":"2019","unstructured":"Niedermeyer S, Murn M, Choi PJ. Respiratory failure in amyotrophic lateral sclerosis. Chest. 2019;155(2):401\u20138. https:\/\/doi.org\/10.1016\/j.chest.2018.06.035.","journal-title":"Chest"},{"issue":"5","key":"1429_CR2","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/S1474-4422(21)00465-8","volume":"21","author":"SA Goutman","year":"2022","unstructured":"Goutman SA, Hardiman O, Al-Chalabi A, Chi\u00f3 A, Savelieff MG, Kiernan MC, et al. Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis. Lancet Neurol. 2022;21(5):480\u201393. https:\/\/doi.org\/10.1016\/S1474-4422(21)00465-8.","journal-title":"Lancet Neurol"},{"key":"1429_CR3","unstructured":"National Institute of Neurological Disorders and Stroke. Amyotrophic Lateral Sclerosis (ALS). https:\/\/www.ninds.nih.gov\/amyotrophic-lateral-sclerosis-als-fact-sheet. Accessed 19 May 2023."},{"issue":"10360","key":"1429_CR4","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/S0140-6736(22)01272-7","volume":"400","author":"EL Feldman","year":"2022","unstructured":"Feldman EL, Goutman SA, Petri S, Mazzini L, Savelieff MG, Shaw PJ, et al. Amyotrophic lateral sclerosis. Lancet. 2022;400(10360):1363\u201380. https:\/\/doi.org\/10.1016\/S0140-6736(22)01272-7.","journal-title":"Lancet"},{"issue":"4","key":"1429_CR5","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1164\/rccm.201111-2042ST","volume":"185","author":"MB Parshall","year":"2012","unstructured":"Parshall MB, Schwartzstein RM, Adams L, Banzett RB, Manning HL, Bourbeau J, et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med. 2012;185(4):435\u201352. https:\/\/doi.org\/10.1164\/rccm.201111-2042ST.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"1429_CR6","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/SPC.0b013e32830c9049","volume":"2","author":"VA Tripodoro","year":"2008","unstructured":"Tripodoro VA, De Vito EL. Management of dyspnea in advanced motor neuron diseases. Curr Opin Support Palliat Care. 2008;2(3):173\u20139. https:\/\/doi.org\/10.1097\/SPC.0b013e32830c9049.","journal-title":"Curr Opin Support Palliat Care"},{"issue":"1","key":"1429_CR7","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1177\/1479972317721557","volume":"15","author":"C Bausewein","year":"2018","unstructured":"Bausewein C, Schunk M, Schumacher P, Dittmer J, Bolzani A, Booth S. Breathlessness services as a new model of support for patients with respiratory disease. Chron Respir Dis. 2018;15(1):48\u201359. https:\/\/doi.org\/10.1177\/1479972317721557.","journal-title":"Chron Respir Dis"},{"issue":"8","key":"1429_CR8","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1136\/thx.2008.104869","volume":"64","author":"J Smith","year":"2009","unstructured":"Smith J, Albert P, Bertella E, Lester J, Jack S, Calverley P. Qualitative aspects of breathlessness in health and disease. Thorax. 2009;64(8):713\u20138. https:\/\/doi.org\/10.1136\/thx.2008.104869.","journal-title":"Thorax"},{"issue":"12","key":"1429_CR9","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1164\/rccm.200711-1675OC","volume":"177","author":"RB Banzett","year":"2008","unstructured":"Banzett RB, Pedersen SH, Schwartzstein RM, Lansing RW. The affective dimension of laboratory dyspnea: air hunger is more unpleasant than work\/effort. Am J Respir Crit Care Med. 2008;177(12):1384\u201390. https:\/\/doi.org\/10.1164\/rccm.200711-1675OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"1429_CR10","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/j.1468-1331.2008.02102.x","volume":"15","author":"KE Clemens","year":"2008","unstructured":"Clemens KE, Klaschik E. Morphine in the management of dyspnoea in ALS. A pilot study. Eur J Neurol. 2008;15(5):445\u201350. https:\/\/doi.org\/10.1111\/j.1468-1331.2008.02102.x.","journal-title":"Eur J Neurol"},{"issue":"46","key":"1429_CR11","doi-asserted-by":"publisher","first-page":"E1453","DOI":"10.1503\/cmaj.191721","volume":"192","author":"C Shoesmith","year":"2020","unstructured":"Shoesmith C, Abrahao A, Benstead T, Chum M, Dupre N, Izenberg A, et al. Canadian best practice recommendations for the management of amyotrophic lateral sclerosis. CMAJ. 2020;192(46):E1453\u20138. https:\/\/doi.org\/10.1503\/cmaj.191721.","journal-title":"CMAJ"},{"issue":"5","key":"1429_CR12","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1212\/WNL.0000000000005916","volume":"91","author":"CJ Creutzfeldt","year":"2018","unstructured":"Creutzfeldt CJ, Kluger B, Kelly AG, Lemmon M, Hwang DY, Galifianakis NB, et al. Neuropalliative care: priorities to move the field forward. Neurology. 2018;91(5):217\u201326. https:\/\/doi.org\/10.1212\/WNL.0000000000005916.","journal-title":"Neurology"},{"issue":"3","key":"1429_CR13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/SPC.0000000000000077","volume":"8","author":"P Allcroft","year":"2014","unstructured":"Allcroft P. Breathlessness in motor neurone disease: a review of the current strategies and gaps in the evidence. Curr Opin Support Palliat Care. 2014;8(3):213\u20137. https:\/\/doi.org\/10.1097\/SPC.0000000000000077.","journal-title":"Curr Opin Support Palliat Care"},{"issue":"3","key":"1429_CR14","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/j.1468-1331.2011.03501.x","volume":"19","author":"PM Andersen","year":"2012","unstructured":"Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS) - revised report of an EFNS task force. Eur J Neurol. 2012;19(3):360\u201375. https:\/\/doi.org\/10.1111\/j.1468-1331.2011.03501.x.","journal-title":"Eur J Neurol"},{"key":"1429_CR15","unstructured":"Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane; 2023. https:\/\/training.cochrane.org\/handbook\/current. Accessed 19 November 2023)."},{"key":"1429_CR16","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jclinepi.2021.03.001","volume":"134","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. J Clin Epidemiol. 2021;134:178\u201389. https:\/\/doi.org\/10.1016\/j.jclinepi.2021.03.001.","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"1429_CR17","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/XEB.0000000000000062","volume":"13","author":"C Lockwood","year":"2015","unstructured":"Lockwood C, Munn Z, Porritt K. Qualitative research synthesis: methodological guidance for systematic reviewers utilizing meta-aggregation. Int J Evid Based Healthc. 2015;13(3):179\u201387. https:\/\/doi.org\/10.1097\/XEB.0000000000000062.","journal-title":"Int J Evid Based Healthc"},{"key":"1429_CR18","doi-asserted-by":"publisher","unstructured":"Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R et al. Chapter 7: Systematic reviews of etiology and risk. In: Aromataris E, Munn Z, editors. JBI Manual for Evidence Synthesis. JBI; 2020. https:\/\/doi.org\/10.46658\/JBIMES-20-08. Accessed 19 May 2023.","DOI":"10.46658\/JBIMES-20-08"},{"key":"1429_CR19","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. https:\/\/doi.org\/10.1136\/bmj.l4898.","journal-title":"BMJ"},{"key":"1429_CR20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1472-684X-10-15","volume":"10","author":"MH Gysels","year":"2011","unstructured":"Gysels MH, Higginson IJ. The lived experience of breathlessness and its implications for care: a qualitative comparison in cancer, COPD, heart failure and MND. BMC Palliat Care. 2011;10:15. https:\/\/doi.org\/10.1186\/1472-684X-10-15.","journal-title":"BMC Palliat Care"},{"issue":"2","key":"1429_CR21","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jpainsymman.2016.02.016","volume":"52","author":"ST Simon","year":"2016","unstructured":"Simon ST, Weing\u00e4rtner V, Higginson IJ, Benalia H, Gysels M, Murtagh FE, et al. I can breathe again! Patients\u2019 self-management strategies for episodic breathlessness in Advanced Disease, Derived from qualitative interviews. J Pain Symptom Manage. 2016;52(2):228\u201334. https:\/\/doi.org\/10.1016\/j.jpainsymman.2016.02.016.","journal-title":"J Pain Symptom Manage"},{"issue":"2","key":"1429_CR22","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1136\/bmjspcare-2014-000788","volume":"7","author":"S Veronese","year":"2017","unstructured":"Veronese S, Gallo G, Valle A, Cugno C, Chi\u00f2 A, Calvo A, et al. Specialist palliative care improves the quality of life in advanced neurodegenerative disorders: NE-PAL, a pilot randomised controlled study. BMJ Support Palliat Care. 2017;7(2):164\u201372. https:\/\/doi.org\/10.1136\/bmjspcare-2014-000788.","journal-title":"BMJ Support Palliat Care"},{"issue":"2","key":"1429_CR23","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1177\/1049909115610078","volume":"34","author":"A Tiirola","year":"2017","unstructured":"Tiirola A, Korhonen T, Surakka T, Lehto JT. End-of-life care of patients with amyotrophic lateral sclerosis and other Nonmalignant diseases. Am J Hosp Palliat Care. 2017;34(2):154\u20139. https:\/\/doi.org\/10.1177\/1049909115610078.","journal-title":"Am J Hosp Palliat Care"},{"issue":"3\u20134","key":"1429_CR24","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1080\/21678421.2022.2096411","volume":"24","author":"S Sennf\u00e4lt","year":"2023","unstructured":"Sennf\u00e4lt S, Kl\u00e4ppe U, Thams S, Samuelsson K, Press R, Fang F, et al. Dying from ALS in Sweden: clinical status, setting, and symptoms. Amyotroph Lateral Scler Frontotemporal Degener. 2023;24(3\u20134):237\u201345. https:\/\/doi.org\/10.1080\/21678421.2022.2096411.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"1429_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.rmed.2018.10.010","volume":"145","author":"C Mor\u00e9lot-Panzini","year":"2018","unstructured":"Mor\u00e9lot-Panzini C, Perez T, Sedkaoui K, de Bock E, Aguilaniu B, Devillier P, et al. The multidimensional nature of dyspnoea in amyotrophic lateral sclerosis patients with chronic respiratory failure: air hunger, anxiety and fear. Respir Med. 2018;145:1\u20137. https:\/\/doi.org\/10.1016\/j.rmed.2018.10.010.","journal-title":"Respir Med"},{"issue":"5","key":"1429_CR26","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/ane.13370","volume":"143","author":"E Eljas Ahlberg","year":"2021","unstructured":"Eljas Ahlberg E, Axelsson B. End-of-life care in amyotrophic lateral sclerosis: a comparative registry study. Acta Neurol Scand. 2021;143(5):481\u20138. https:\/\/doi.org\/10.1111\/ane.13370.","journal-title":"Acta Neurol Scand"},{"issue":"9","key":"1429_CR27","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1177\/1049909120969959","volume":"38","author":"AK Mehta","year":"2021","unstructured":"Mehta AK, Jackson NJ, Wiedau-Pazos M. Palliative Care consults in an inpatient setting for patients with amyotrophic lateral sclerosis. Am J Hosp Palliat Care. 2021;38(9):1091\u20138. https:\/\/doi.org\/10.1177\/1049909120969959.","journal-title":"Am J Hosp Palliat Care"},{"issue":"1","key":"1429_CR28","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/ene.12889","volume":"23","author":"DJ Oliver","year":"2016","unstructured":"Oliver DJ, Borasio GD, Caraceni A, de Visser M, Grisold W, Lorenzl S, et al. A consensus review on the development of palliative care for patients with chronic and progressive neurological disease. Eur J Neurol. 2016;23(1):30\u20138. https:\/\/doi.org\/10.1111\/ene.12889.","journal-title":"Eur J Neurol"},{"issue":"1","key":"1429_CR29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3390\/bs10010033","volume":"10","author":"L Bond","year":"2020","unstructured":"Bond L, Bowen G, Mertens B, Denson K, Jordan K, Vidakovic B, et al. Associations of patient mood, modulators of quality of life, and pharmaceuticals with amyotrophic lateral sclerosis survival duration. Behav Sci (Basel). 2020;10(1):33. https:\/\/doi.org\/10.3390\/bs10010033.","journal-title":"Behav Sci (Basel)"},{"issue":"15","key":"1429_CR30","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1212\/WNL.0b013e3181bc0141","volume":"73","author":"RG Miller","year":"2009","unstructured":"Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality standards Subcommittee of the American Academy of Neurology. Neurology. 2009;73(15):1218\u201326. https:\/\/doi.org\/10.1212\/WNL.0b013e3181bc0141.","journal-title":"Neurology"},{"key":"1429_CR31","unstructured":"National Quality Forum. Palliative and End-of-Life Care 2015\u20132016. Dec 2016. https:\/\/www.qualityforum.org\/Palliative_and_End-of-Life_Care_Project_2015-2016.aspx. Accessed 19 May 2023."},{"key":"1429_CR32","unstructured":"National Institute for Health and Clinical Excellence (NICE). Motor neurone disease: assessment and management. NICE guidelines NG 42. London: NICE. 2016. https:\/\/www.nice.org.uk\/guidance\/ng42. Accessed 19 May 2023."},{"issue":"2","key":"1429_CR33","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S1474-4422(05)70326-4","volume":"5","author":"SC Bourke","year":"2006","unstructured":"Bourke SC, Tomlinson M, Williams TL, Bullock RE, Shaw PJ, Gibson GJ. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol. 2006;5(2):140\u20137. https:\/\/doi.org\/10.1016\/S1474-4422(05)70326-4.","journal-title":"Lancet Neurol"},{"key":"1429_CR34","doi-asserted-by":"publisher","first-page":"147997312311759","DOI":"10.1177\/14799731231175915","volume":"20","author":"P Sales de Campos","year":"2023","unstructured":"Sales de Campos P, Olsen WL, Wymer JP, Smith BK. Respiratory therapies for amyotrophic lateral sclerosis: a state of the art review. Chron Respir Dis. 2023;20:14799731231175915. https:\/\/doi.org\/10.1177\/14799731231175915.","journal-title":"Chron Respir Dis"},{"issue":"10","key":"1429_CR35","doi-asserted-by":"publisher","first-page":"CD004427","DOI":"10.1002\/14651858.CD004427.pub4","volume":"10","author":"A Radunovic","year":"2017","unstructured":"Radunovic A, Annane D, Rafiq MK, Brassington R, Mustfa N. Mechanical ventilation for amyotrophic lateral sclerosis\/motor neuron disease. Cochrane Database Syst Rev. 2017;10(10):CD004427. https:\/\/doi.org\/10.1002\/14651858.CD004427.pub4.","journal-title":"Cochrane Database Syst Rev"},{"issue":"7\u20138","key":"1429_CR36","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1080\/21678421.2019.1627372","volume":"20","author":"SK Baxter","year":"2019","unstructured":"Baxter SK, Johnson M, Clowes M, O\u2019Brien D, Norman P, Stavroulakis T, et al. Optimizing the noninvasive ventilation pathway for patients with amyotrophic lateral sclerosis\/motor neuron disease: a systematic review. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20(7\u20138):461\u201372. https:\/\/doi.org\/10.1080\/21678421.2019.1627372.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"4","key":"1429_CR37","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1136\/thx.54.4.367","volume":"54","author":"MI Polkey","year":"1999","unstructured":"Polkey MI, Lyall RA, Davidson AC, Leigh PN, Moxham J. Ethical and clinical issues in the use of home non-invasive mechanical ventilation for the palliation of breathlessness in motor neurone disease. Thorax. 1999;54(4):367\u201371. https:\/\/doi.org\/10.1136\/thx.54.4.367.","journal-title":"Thorax"},{"key":"1429_CR38","unstructured":"Association for Palliative Medicine of Great Britain and Ireland. Withdrawal of assisted ventilation at the request of a patient with motor neurone disease: guidance for professionals. Nov 2015. https:\/\/apmonline.org\/wp-content\/uploads\/2016\/03\/Guidance-with-logos-updated-210316.pdf. Accessed 03 April 2024."},{"issue":"3","key":"1429_CR39","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/mus.22305","volume":"45","author":"LJ Blackhall","year":"2012","unstructured":"Blackhall LJ. Amyotrophic lateral sclerosis and palliative care: where we are, and the road ahead. Muscle Nerve. 2012;45(3):311\u20138. https:\/\/doi.org\/10.1002\/mus.22305.","journal-title":"Muscle Nerve"},{"issue":"1","key":"1429_CR40","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.neuroimage.2009.06.015","volume":"48","author":"A von Leupoldt","year":"2009","unstructured":"von Leupoldt A, Sommer T, Kegat S, Baumann HJ, Klose H, Dahme B, et al. Dyspnea and pain share emotion-related brain network. NeuroImage. 2009;48(1):200\u20136. https:\/\/doi.org\/10.1016\/j.neuroimage.2009.06.015.","journal-title":"NeuroImage"},{"issue":"8","key":"1429_CR41","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1164\/rccm.201101-0005OC","volume":"184","author":"RB Banzett","year":"2011","unstructured":"Banzett RB, Adams L, O\u2019Donnell CR, Gilman SA, Lansing RW, Schwartzstein RM. Using laboratory models to test treatment: morphine reduces dyspnea and hypercapnic ventilatory response. Am J Respir Crit Care Med. 2011;184(8):920\u20137. https:\/\/doi.org\/10.1164\/rccm.201101-0005OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"1429_CR42","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1191\/026921698677326556","volume":"12","author":"D Oliver","year":"1998","unstructured":"Oliver D. Opioid medication in the palliative care of motor neurone disease. Palliat Med. 1998;12(2):113\u20135. https:\/\/doi.org\/10.1191\/026921698677326556.","journal-title":"Palliat Med"},{"issue":"6","key":"1429_CR43","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/resp.13525","volume":"24","author":"C Morelot-Panzini","year":"2019","unstructured":"Morelot-Panzini C, Bruneteau G, Gonzalez-Bermejo J. NIV in amyotrophic lateral sclerosis: the \u2018when\u2019 and \u2018how\u2019 of the matter. Respirology. 2019;24(6):521\u201330. https:\/\/doi.org\/10.1111\/resp.13525.","journal-title":"Respirology"},{"issue":"1","key":"1429_CR44","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s13760-023-02344-5","volume":"124","author":"R Morishima","year":"2024","unstructured":"Morishima R, Shimizu T, Kimura H, Bokuda K, Saotome T, Nakayama Y, et al. High doses of opioids usage for amyotrophic lateral sclerosis patients with non-invasive ventilation. Acta Neurol Belg. 2024;124(1):101\u20137. https:\/\/doi.org\/10.1007\/s13760-023-02344-5.","journal-title":"Acta Neurol Belg"},{"issue":"3","key":"1429_CR45","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.jpainsymman.2010.11.021","volume":"42","author":"DC Currow","year":"2011","unstructured":"Currow DC, McDonald C, Oaten S, Kenny B, Allcroft P, Frith P, Briffa M, Johnson MJ, Abernethy AP. Once-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance study. J Pain Symptom Manage. 2011;42(3):388\u201399. https:\/\/doi.org\/10.1016\/j.jpainsymman.2010.11.021.","journal-title":"J Pain Symptom Manage"},{"issue":"1","key":"1429_CR46","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12955-019-1167-0","volume":"17","author":"S Vogt","year":"2019","unstructured":"Vogt S, Schreiber S, Heinze HJ, Dengler R, Petri S, Vielhaber S. The Dyspnea-ALS-Scale (DALS-15) optimizes individual treatment in patients with amyotrophic lateral sclerosis (ALS) suffering from dyspnea. Health Qual Life Outcomes. 2019;17(1):95. https:\/\/doi.org\/10.1186\/s12955-019-1167-0.","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"1429_CR47","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1089\/pmr.2020.0084","volume":"2","author":"K Takahashi","year":"2021","unstructured":"Takahashi K, Murakami F, Komai K, Ishida C, Kato-Motozaki Y. Difference in the care of patients with amyotrophic lateral sclerosis with and without intervention from the palliative care team: observations from a center in Japan. Palliat Med Rep. 2021;2(1):201\u20136. https:\/\/doi.org\/10.1089\/pmr.2020.0084.","journal-title":"Palliat Med Rep"},{"key":"1429_CR48","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2147\/DNND.S85103","volume":"6","author":"DJ Oliver","year":"2016","unstructured":"Oliver DJ. Palliative care for patients with motor neurone disease: current challenges. Degener Neurol Neuromuscul Dis. 2016;6:65\u201372. https:\/\/doi.org\/10.2147\/DNND.S85103.","journal-title":"Degener Neurol Neuromuscul Dis"},{"issue":"4","key":"1429_CR49","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/SPC.0000000000000098","volume":"8","author":"JM L\u00f3pez-Saca","year":"2014","unstructured":"L\u00f3pez-Saca JM, Centeno C. Opioids prescription for symptoms relief and the impact on respiratory function: updated evidence. Curr Opin Support Palliat Care. 2014;8(4):383\u201390. https:\/\/doi.org\/10.1097\/SPC.0000000000000098.","journal-title":"Curr Opin Support Palliat Care"},{"key":"1429_CR50","doi-asserted-by":"publisher","first-page":"1701153","DOI":"10.1183\/13993003.01153-2017","volume":"50","author":"CA Verberkt","year":"2017","unstructured":"Verberkt CA, van den Beuken MHJ, Schols JMGA, Datla S, Dirksen CD, Johnson MJ, et al. Respiratory adverse effects of opioids for breathlessness: a systematic review and metaanalysis. Eur Respir J. 2017;50:1701153. https:\/\/doi.org\/10.1183\/13993003.01153-2017.","journal-title":"Eur Respir J"},{"issue":"1","key":"1429_CR51","doi-asserted-by":"publisher","first-page":"CD002990","DOI":"10.1002\/14651858.CD002990.pub4","volume":"1","author":"J Schrijver","year":"2022","unstructured":"Schrijver J, Lenferink A, Brusse-Keizer M, Zwerink M, van der Valk PD, van der Palen J, et al. Self-management interventions for people with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2022;1(1):CD002990. https:\/\/doi.org\/10.1002\/14651858.CD002990.pub4.","journal-title":"Cochrane Database Syst Rev"}],"container-title":["BMC Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12904-024-01429-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12904-024-01429-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12904-024-01429-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T00:16:47Z","timestamp":1713226607000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpalliatcare.biomedcentral.com\/articles\/10.1186\/s12904-024-01429-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,16]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1429"],"URL":"https:\/\/doi.org\/10.1186\/s12904-024-01429-z","relation":{},"ISSN":["1472-684X"],"issn-type":[{"value":"1472-684X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,16]]},"assertion":[{"value":"11 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests in this section.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"100"}}